Verified stock price
Inhibikase Therapeutics (IKT) Stock Price and Company Data
Direct answer
Inhibikase Therapeutics (IKT) trades at $2.30.
The verified 52-week trading range is $1.33 to $2.61.
The data was observed on September 19, 2026. Missing values are not estimated.
Market data checked September 19, 2026.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current stock price
- $2.30
- 52-week price range
- $1.33 to $2.61
- Ticker
- IKT
- Market
- United States
- Data snapshot
- September 20, 2026
- Verified data surfaces
- financials, forecast, metrics, earnings, comparison